
TY  - JOUR
TI  - Poster Session 1: Mechanisms of Injury
JO  - Hepatology
JA  - Hepatology
VL  - 60
IS  - S1
SN  - 0270-9139
UR  - https://doi.org/10.1002/hep.27508
DO  - doi:10.1002/hep.27508
SP  - 517A
EP  - 522A
PY  - 2014
ER  - 

TY  - JOUR
AU  - SUNAHARA, F.A.
AU  - TALESNIK, J.
TI  - MYOCARDIAL SYNTHESIS OF PROSTAGLANDIN-LIKE SUBSTANCES AND CORONARY REACTIONS TO CARDIOSTIMULATION AND TO HYPOXIA
JO  - British Journal of Pharmacology
VL  - 65
IS  - 1
SN  - 0007-1188
UR  - https://doi.org/10.1111/j.1476-5381.1979.tb17335.x
DO  - doi:10.1111/j.1476-5381.1979.tb17335.x
SP  - 71
EP  - 85
PY  - 1979
AB  - 1 Continuous recording of cardiac contractions and coronary flow from isolated perfused hearts of rats permitted the study of coronary reactions to: (a) cardiostimulation induced by single doses or slow infusions of noradrenaline, CaCl2, glucagon or electrically induced tachycardia; (b) short interruptions of coronary inflow (hypoxia). 2 Except during tachycardia the heart rate was kept constant at 210 beats/min by electrical pacing. 3 Metabolic coronary vasodilatation (MCD) resulting from cardiac hyperactivity induced by noradrenaline, Ca2+, tachycardia or glucagon was inhibited by administration of prostaglandin E2. Reactive hyperaemia response to hypoxia was unaffected by prostaglandin administration. 4 Inhibition of MCD could also be obtained by prolonged infusion with arachidonic acid (1.6 ? 10?7m), presumably by its conversion into prostaglandin-like substance since arachidonic acid failed to block MCD in hearts from rats pretreated with non-steroidal anti-inflammatory drugs (indomethacin, naproxen, phenylbutazone). 5 Reactive hyperaemia was unaffected either by arachidonic acid or by blockade of the synthesis of prostaglandin-like substances by anti-inflammatory drugs. 6 Since prostaglandin synthetase inhibition does not prevent but may enhance MCD, we do not advocate prostaglandin-like substances as agents directly responsible for the coronary vasodilatation that follows cardiac hyperactivity. 7 We postulate that cardiac overproduction of prostaglandins may lead to a failure in the adaptive coronary flow response to cardiac hyperactivity (coronary insufficiency?).
ER  - 

TY  - JOUR
TI  - ICS 2017 Abstracts
JO  - Neurourology and Urodynamics
JA  - Neurourol. Urodynam.
VL  - 36
IS  - S3
SN  - 0733-2467
UR  - https://doi.org/10.1002/nau.23386
DO  - doi:10.1002/nau.23386
SP  - S1
EP  - S575
PY  - 2017
AB  - Watch ICS 2017 Abstract Videos Online
ER  - 

TY  - JOUR
AU  - Nagel, Sean J.
AU  - Reddy, Chandan G.
AU  - Frizon, Leonardo A.
AU  - Holland, Marshall T.
AU  - Machado, Andre G.
AU  - Gillies, George T.
AU  - Howard III, Matthew A.
TI  - Intrathecal Therapeutics: Device Design, Access Methods, and Complication Mitigation
JO  - Neuromodulation: Technology at the Neural Interface
JA  - Neuromodulation: Technology at the Neural Interface
VL  - 21
IS  - 7
SN  - 1094-7159
UR  - https://doi.org/10.1111/ner.12693
DO  - doi:10.1111/ner.12693
SP  - 625
EP  - 640
KW  - Intrathecal delivery
KW  - spinal canal
KW  - spinal cord stimulation
KW  - spinal cord
KW  - thecal sac
PY  - 2018
AB  - Introduction The intrathecal space remains underutilized for diagnostic testing, invasive monitoring or as a pipeline for the delivery of neurological therapeutic agents and devices. The latter including drug infusions, implants for electrical modulation, and a means for maintaining the physiologic pressure column. The reasons for this are many but include unfamiliarity with the central nervous system and the historical risks that continue to overshadow the low complication rates in modern clinical series. Materials and Methods Our intent in this review is to explore the access devices currently on the market, assess the risk associated with breaching the intrathecal space, and propose a research model for bringing to patients the next generation of intrathecal hardware. For this purpose, we reviewed both historical and contemporary literature that pertains to the access devices and catheters intended for both temporary and permanent implantation and the complications thereof. Results There are few devices that are currently marketed in the United States or Europe for intrathecal use. Most hew to a relatively fixed design pattern predicated on the dimensions and properties of the thecal sac. All are typically composed of soft silicone, and employ a Tuohy needle for access despite design limitations. In general, these catheters are engineered for durability, ease of use, and regional deployment. Devices on the market with steerability or targeted intrathecal fixation are not yet available. Complications, once a legitimate concern, are now quite rare when recommended techniques are followed. Conclusions Over the next decade, advances in intrathecal catheter design, access techniques, imaging, and greater understanding of the spinal cord neurophysiology will usher in an era where the intrathecal space is recognized as a highly valued diagnostic and therapeutic target. We anticipate that this will occur in several concurrent phases, each with the potential to accelerate the growth of the others.
ER  - 

TY  - JOUR
TI  - Cellular Neurophysiology C37-C58, PC19-PC32
JO  - The Journal of Physiology
JA  - The Journal of Physiology
VL  - 555
IS  - suppl
SN  - 0022-3751
UR  - https://doi.org/10.1111/j.1469-7793.2004.tb00480.x
DO  - doi:10.1111/j.1469-7793.2004.tb00480.x
SP  - 1P
EP  - 16P
PY  - 2004
ER  - 

TY  - JOUR
TI  - P1198 - P1459
JO  - Clinical Microbiology and Infection
VL  - 12
IS  - s4
SN  - 1198-743X
UR  - https://doi.org/10.1111/j.1470-9465.2006.12_4_1430.x
DO  - doi:10.1111/j.1470-9465.2006.12_4_1430.x
PY  - 2006
ER  - 

TY  - JOUR
TI  - Friday 5 September 2014
JO  - Journal of Medical Imaging and Radiation Oncology
JA  - Journal of Medical Imaging and Radiation Oncology
VL  - 58
IS  - S1
SN  - 1754-9477
UR  - https://doi.org/10.1111/1754-9485.12220
DO  - doi:10.1111/1754-9485.12220
SP  - 63
EP  - 112
PY  - 2014
ER  - 

TY  - JOUR
TI  - 28th Annual Meeting of the Wound Healing Society, SAWC-Spring/WHS Joint Meeting: Georgia World Congress Center, Atlanta, Georgia, USA, April 13–17, 2016
JO  - Wound Repair and Regeneration
JA  - Wound Rep Reg
VL  - 24
IS  - 2
SN  - 1067-1927
UR  - https://doi.org/10.1111/wrr.12405
DO  - doi:10.1111/wrr.12405
SP  - A1
EP  - A34
PY  - 2016
ER  - 

TY  - JOUR
TI  - Abstracts
JO  - International Journal of Stroke
VL  - 3
IS  - s1
SN  - 1747-4930
UR  - https://doi.org/10.1111/j.1747-4949.2008.00231.x
DO  - doi:10.1111/j.1747-4949.2008.00231.x
SP  - 2
EP  - 474
PY  - 2008
ER  - 

TY  - JOUR
TI  - 30th ASN MEETING, NEW ORLEANS, LOUISIANA
JO  - Journal of Neurochemistry
VL  - 72
IS  - s1
SN  - 0022-3042
UR  - https://doi.org/10.1111/j.1471-4159.1999.tb11579.x
DO  - doi:10.1111/j.1471-4159.1999.tb11579.x
SP  - S1
EP  - S91
PY  - 1999
ER  - 

TY  - JOUR
TI  - Abstracts
JO  - Alcoholism: Clinical and Experimental Research
VL  - 14
IS  - 2
SN  - 0145-6008
UR  - https://doi.org/10.1111/j.1530-0277.1990.tb00486.x
DO  - doi:10.1111/j.1530-0277.1990.tb00486.x
SP  - 264
EP  - 356
PY  - 1990
ER  - 

TY  - JOUR
AU  - Taylor, Frederick R.
AU  - Stillman, Mark
AU  - Tepper, Stewart J.
TI  - Abstracts and Citations
JO  - Headache: The Journal of Head and Face Pain
VL  - 47
IS  - 9
SN  - 0017-8748
UR  - https://doi.org/10.1111/j.1526-4610.2007.00927.x
DO  - doi:10.1111/j.1526-4610.2007.00927.x
SP  - 1354
EP  - 1364
PY  - 2007
ER  - 

TY  - JOUR
TI  - Poster Sessions Tuesday/Wednesday
JO  - Journal of Neurochemistry
JA  - J. Neurochem.
VL  - 125
IS  - s1
SN  - 0022-3042
UR  - https://doi.org/10.1111/jnc.12186
DO  - doi:10.1111/jnc.12186
SP  - 194
EP  - 280
PY  - 2013
ER  - 

TY  - JOUR
TI  - Friday 5 September 2014
JO  - Journal of Medical Radiation Sciences
JA  - J Med Radiat Sci
VL  - 61
IS  - S1
SN  - 2051-3895
UR  - https://doi.org/10.1002/jmrs.71
DO  - doi:10.1002/jmrs.71
SP  - 63
EP  - 112
PY  - 2014
ER  - 

TY  - JOUR
TI  - Sunday 31 August Monday 1 September Tuesday 2 September
JO  - European Journal of Neurology
VL  - 10
IS  - s1
SN  - 1351-5101
UR  - https://doi.org/10.1046/j.1468-1331.10.s1.2.x
DO  - doi:10.1046/j.1468-1331.10.s1.2.x
SP  - 8
EP  - 44
PY  - 2003
ER  - 

TY  - JOUR
TI  - Abstracts of the 10th Meeting of the Italian Peripheral Nerve Study Group
JO  - Journal of the Peripheral Nervous System
VL  - 11
IS  - 2
SN  - 1085-9489
UR  - https://doi.org/10.1111/j.1085-9489.2006.00086.x
DO  - doi:10.1111/j.1085-9489.2006.00086.x
SP  - 179
EP  - 208
PY  - 2006
ER  - 

TY  - JOUR
TI  - Poster Presentations
JO  - Pediatric Dermatology
JA  - Pediatr Dermatol
VL  - 34
IS  - S2
SN  - 0736-8046
UR  - https://doi.org/10.1111/pde.13268
DO  - doi:10.1111/pde.13268
SP  - S19
EP  - S56
PY  - 2017
ER  - 

TY  - JOUR
TI  - The International Liver Transplantation Society: 14th Annual International Congress, July 9–12, 2008, Paris, France
JO  - Liver Transplantation
JA  - Liver Transpl
VL  - 14
IS  - S1
SN  - 1527-6465
UR  - https://doi.org/10.1002/lt.21569
DO  - doi:10.1002/lt.21569
SP  - S1
EP  - S269
PY  - 2008
ER  - 

TY  - JOUR
TI  - Absracts
JO  - Vox Sanguinis
VL  - 83
IS  - S2
SN  - 0042-9007
UR  - https://doi.org/10.1111/j.1423-0410.2002.tb05391.x
DO  - doi:10.1111/j.1423-0410.2002.tb05391.x
SP  - 1
EP  - 236
PY  - 2002
ER  - 

TY  - JOUR
TI  - Orals
JO  - Transplant International
JA  - Transpl Int
VL  - 28
IS  - S4
SN  - 0934-0874
UR  - https://doi.org/10.1111/tri.12701
DO  - doi:10.1111/tri.12701
SP  - 134
EP  - 276
PY  - 2015
ER  - 
